BTIG Downgrades Macrogenics to Neutral
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Kaveri Pohlman has downgraded Macrogenics (NASDAQ:MGNX) from Buy to Neutral.
August 01, 2024 | 6:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BTIG analyst Kaveri Pohlman has downgraded Macrogenics from Buy to Neutral, which may indicate a less optimistic outlook for the company's stock performance.
The downgrade from Buy to Neutral by a reputable analyst can lead to a negative sentiment among investors, potentially causing a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100